DBV Technologies SA (DBVT)
11.02
-0.42
(-3.63%)
USD |
NASDAQ |
Nov 13, 16:00
11.11
+0.10
(+0.86%)
Pre-Market: 19:59
DBV Technologies Shareholders Equity (Quarterly) : 148.60M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 148.60M |
| June 30, 2026 | |
| March 31, 2026 | 207.90M |
| December 31, 2025 | 168.77M |
| September 30, 2025 | 52.85M |
| June 30, 2025 | 86.22M |
| March 31, 2025 | 2.873M |
| December 31, 2024 | 27.39M |
| September 30, 2024 | 54.03M |
| June 30, 2024 | 79.10M |
| March 31, 2024 | 111.65M |
| December 31, 2023 | 140.19M |
| Date | Value |
|---|---|
| September 30, 2023 | 143.99M |
| June 30, 2023 | 164.24M |
| March 31, 2023 | 179.09M |
| December 31, 2022 | 194.45M |
| September 30, 2022 | 212.05M |
| June 30, 2022 | 244.42M |
| March 31, 2022 | 82.06M |
| December 31, 2021 | 99.03M |
| September 30, 2021 | 116.89M |
| June 30, 2021 | 143.02M |
| March 31, 2021 | 169.18M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cellectis SA | 41.07M |
| Akari Therapeutics Plc | 17.50M |
| Bicycle Therapeutics Plc | 505.28M |
| EDAP TMS SA | 35.94M |
| Autolus Therapeutics Plc | 27.40M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 215.40M |
| Total Liabilities (Quarterly) | 66.70M |
| Debt to Equity Ratio | 0.1494 |
| Current Ratio | 3.241 |
| Net Debt Paydown Yield | -0.21% |